Number of shares outstanding for Oramed Pharmaceuticals (ORMP)

Number of shares outstanding as of October 2026 : 41,040,479

According to Oramed Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 41,040,479. At the end of 2026 the company had 41,040,479 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Oramed Pharmaceuticals from 2013 to 2026

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2026	41.04 M	-1.71%
2025	41.75 M	2.1%
2024	40.89 M	1.11%
2023	40.44 M	3.44%
2022	39.1 M	6.62%
2021	36.67 M	54.38%
2020	23.75 M	35.96%
2019	17.47 M	0.14%
2018	17.44 M	22.54%
2017	14.23 M	7.83%
2016	13.2 M	14.11%
2015	11.57 M	14.11%
2014	10.14 M	27.72%
2013	7.94 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Novo Nordisk NVO	4,428,059,072	10,689.49%	🇩🇰 Denmark
Sanofi SNY	2,393,200,000	5,731.32%	🇫🇷 France
Ultragenyx Pharmaceutical RARE	101,900,000	148.29%	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	437,653,000	966.39%	🇺🇸 USA
Compugen CGEN	94,640,696	130.60%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions